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WNT and BMP signaling are both required for
hematopoietic cell development from human ES cells
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Received 12 February 2009; received in revised form 29 May 2009; accepted 5 June 2009Abstract Pluripotent human embryonic stem (hES) cells are capable of generating a variety of mature cell types, including
hematopoietic cells in vitro. However, the precise signaling mechanisms that regulate hematopoietic cell development from hES
cells are still poorly documented. Here we demonstrate that hemoangiogenic cells derived from hES cells are defined by their
high-level expression of KDR and low-level expression of PDGFRα (KDR+PDGFRαlo), and that the generation of such cells from hES
cells is significantly elevated by the addition of WNT3a or BMP4 during differentiation. The addition of WNT3a caused the
induction of both hemogenic and angiogenic activities, and the addition of BMP4 preferentially increased angiogenic activity, all
enriched in the KDR+PDGFRαlo cell fraction. Interestingly, WNT3a stimulation of hemoangiogenic cell genesis was virtually
abolished in the presence of a BMP inhibitor. On the other hand, the BMP4-induced angiogenic cell genesis was suppressed by
coaddition of a WNT inhibitor. Thus, WNT and BMP signaling coordinately direct the differentiation of hES cells into
KDR+PDGFRαlo hemoangiogenic cells.
© 2009 Elsevier B.V. All rights reserved.Introduction
Pluripotent human embryonic stem (hES) cells are able to
generate a variety of cell types and are therefore considered
a useful tool for the study of early events occurring during
embryogenesis. Although progress has been made toward the
generation of hematopoietic progenitor cells from hES cells,
the precise signaling mechanism that regulates this process is
still poorly documented.
During mouse embryogenesis, hematopoietic cell devel-
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doi:10.1016/j.scr.2009.06.001cluster of progenitors arise in the posterior region of the
primitive streak expressing early mesoderm markers such
as Brachyury (T) and endothelial cell markers such as
vascular endothelial growth factor receptor 2 (VEGFR2,
KDR, or FLK1) (Huber et al., 2004). The progenitors, that
later express vascular endothelial cadherin (VE-cadherin or
CDH5) are able to undergo hematopoietic and endothelial
cell lineage commitment before the establishment of yolk
sac blood islands (Nishikawa et al., 1998a; Moore and
Metcalf, 1970; Palis et al., 1999). In support of these in
vivo observations, studies using the in vitro mouse ES (mES)
cell differentiation model have identified a subset of
clonogenic progenitors capable of giving rise to both
hematopoietic and endothelial cells (Choi et al., 1998),
consistent with the hypothesis that the early hematopoie-
tic and endothelial progenitors in yolk sac originate from a
common precursor, hemangioblast or early hemogenic
mesoderm (Choi, 2002; Keller, 2005; Nishikawa et al.,
2007)..
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inaccessible, studies with a later stage of human embryos
have demonstrated that the earliest hematopoiesis also
occurs within blood islands in the yolk sac (Kelemen et al.,
1979; Tavian et al., 1999; Tavian and Peault, 2005; Palis and
Yoder, 2001). With strategies similar to those used for mES
cells, several groups have reported that hematopoietic cells
and their (hemogenic) precursor cells can be generated from
hES cells using the embryoid body (EB) formation method and
stromal cell coculture method (Kaufman et al., 2001;
Chadwick et al., 2003; Wang et al., 2004; Vodyanik et al.,
2005; Qiu et al., 2005; Kennedy et al., 2007). HES-derived
nonhematopoietic (i.e., CD45-) progenitors expressing
PECAM1 (CD31), FLK1, and VE-cadherin (CD45-PFV cells)
(Wang et al., 2004) or those expressing CD34 and CD31
(CD34+CD31+CD45- cells) are hemoangiogenic, i.e., capable
of generating both hematopoietic and endothelial cells (Wang
et al., 2004; Zambidis et al., 2005). Furthermore, the
CD34brightCD31+FLK1+ cell fraction is enriched for hemoan-
giogenic activity whereas CD34dimCD45+ cells are committed
to the hematopoietic lineage (Woll et al., 2008).
WNTand bone morphogenetic protein (BMP) signaling are
indispensable in the specification and formation of hemo-
genic mesoderm. Firstly, mouse mutant analyses have
demonstrated an essential role for canonical WNT signaling
in the formation of primitive streak. Mice lacking Wnt3, Lrp6
(WNT receptor for canonical signaling), or β-catenin (intra-
cellular component for canonical signaling) do not develop a
primitive streak (Liu et al., 1999; Kelly et al., 2004; Huelsken
et al., 2000). Furthermore, all BMP receptor 2 null mutant
mice and a subpopulation of BMP receptor 1A-deficient or
BMP4-deficient mice also fail to undergo gastrulation (Mis-
hina et al., 1995; Winnier et al., 1995; Beppu et al., 2000).
These mutants fail to generate mesodermal lineages, includ-
ing hematopoietic cells. Secondly, during in vitro mES cell
differentiation, BMP signaling is essential for inducing
lymphohematopoietic cells in the presence of VEGF
(Nakayama et al., 2000), and the FLK1+PDGFRα- progeny
represent the hemogenic activity (Nakayama et al., 2003).
WNT is required for the FLK1+ mesoderm to give rise to
hematopoietic progenitor cells, and BMP displays a strong
posteriorizing effect on the FLK1+ cells (Nostro et al., 2008).
Our studies have demonstrated that exogenous WNT3a
requires BMP signaling to induce FLK1+ hemogenic mesoderm
from mES cells (M. Tanaka, submitted for publication).
We have addressed whether both WNT and BMP
signaling are required for specifying and generating
hemoangiogenic mesodermal cells from hES cells. BMP4,
especially when combined with VEGF, facilitates hemato-
poietic differentiation from ES cells (Chadwick et al.,
2003; Kennedy et al., 2007), and canonical Wnt signaling
also enhances the process, especially on mouse stromal
cells in a serum-containing medium (Woll et al., 2008).
Using a serum-free EB formation culture method for
differentiation, in which hemogenic activity is developed
in response to exogenously provided WNT3a, we have
demonstrated that (1) WNT3a alone supports hemoangio-
genic cell generation from hES cells, (2) BMP4 alone
preferentially stimulates endothelial cell development,
and (3) in either case, both WNT and BMP signaling are
eventually activated, which is necessary for displaying such
WNT3a or BMP4 effects.Results
WNT and BMP signaling are involved in generating
KDR+ progeny from hES cellsTo define the key signaling pathways that regulate hemato-
poietic commitment of hES cells, we used a serum-free,
semisolid culture method that allowed the hES cells to
differentiate in the form of an EB, in an exogenous factor-
dependent manner. Two surface markers, KDR (or FLK1) and
PDGFRα, used to detect the mesodermal cell genesis from
mouse (m)ES cells (Chung et al., 2002; Kataoka et al., 1997;
Nishikawa et al., 1998b; Orr-Urtreger et al., 1992; Yamashita
et al., 2000; Takakura et al., 1997), were applied to monitor
the progress of hES cell differentiation (Fig. 1A). Accumulation
of a lower percentage of PDGFRα+ cells in the absence of
exogenous protein factors was noted. However, when BMP4 at
10ng/ml or greater orWNT3aat 50 ng/mlor greaterwas added
fromDay 0 of differentiation, four subpopulationswere readily
detected by Day 5 of differentiation: KDR-PDGFRα- (double
negative DN), KDR-PDGFRα+, KDR+PDGFRα+ (double positive
DP), and KDR+PDGFRαlo. The KDR-PDGFRα+ and DP populations
were not well separated, and in most cases, may be the same
population of cells. However, here we arbitrarily treat them
separately. The effective dosages of BMP4 and WNT3a were
determined by monitoring the levels of KDR+ or PDGFRα+
progeny generated in 5–8 days of hES cell differentiation
(example shown in Fig. 1A, right).
Exogenous BMP4 preferentially enhanced the accumulation
of PDGFRα+ progeny (black and red dots, Fig. 1A, left),
particularly the DP cell population (red dots), during hES cell
differentiation. In contrast, exogenous WNT3a preferentially
induced the KDR+PDGFRαlo cell population (green dots) in a
dose dependent manner (Fig. 1A, right). Thus, BMP and WNT
signaling may differentially affect the generation of KDR+
progeny from hES cells. Under either condition, the KDR+
subpopulations increased in a time-dependent manner. The
KDR+PDGFRαlo cell population could be detected from Day 4 to
5 and reached the maximum level by Day 8 (Supplemental
Figure 1 or S.Fig.1). No CD45+ hematopoietic progenitor-like
cells were detected during this period (data not shown).
However, given that expression of KDR represents the
emergence of hemoangiogenic mesoderm during early mouse
embryogenesis (Huber et al., 2004), a marked increase in the
levels of KDR+ progeny in response to exogenous WNT3a or
BMP4 suggests that this culture system is suitable for
addressing the effects of WNT and BMP signaling on the
hematopoietic differentiation of hES cells, in particular on the
early prehematopoietic (i.e., hemoangiogenic mesoderm or
hemogenic endothelium) stage.
Next, we examined expression of mesoderm transcripts,
including those directly involved in the development of
hematopoietic and endothelial cells (Fig. 1B). OCT4 mRNA,
encoding a transcription factor representing undifferentiated
hES cells was down-regulated rapidly by Day 8 of differentia-
tion, regardless of added factors. Two early mesodermmarkers,
T and MESP1 (Saga et al., 1996), and the lateral plate/
extraembryonic mesoderm marker FOXF1 (Mahlapuu et al.,
2001) were transiently expressed when BMP4 (pink line) or
WNT3a (green line) was added. The highest level ofTexpression
was observed around Day 2, that of MESP1 expression was
Figure 1 Expression of surface antigens and gene transcripts during human ES cell differentiation. (A) Flow cytometric analysis of EB
cells formed in the serum-free semisolid culture. HES3 cells were differentiated in the presence of no factor (None), 10 ng/ml BMP4
(BMP), or 100 ng/ml WNT3a (WNT), and were FACS-analyzed on Day 5 and Day 8. The KDR-PDGFRα+, KDR+PDGFRα+(DP), and
KDR+PDGFRαlo cell populations are represented as black, red, and green dots, respectively (left panels). The percentage of total EB
cells in each fraction is also shown in the corresponding color. The percentage of KDR+PDGFRαlo (K+Plo) cells from Day 5 (□) and Day 8
(◼) EBs generated in the presence of no growth factor (0), 10 or 50 ng/ml BMP4 (BMP 10, 50), or 25, 50, or 100 ng/ml WNT3a (WNT 25,
50, 100) was individually averaged over 2 to 8 independent experiments, and is summarized in the right graph. The error bars are based
on SD. A similar analysis was done with EBs generated in the presence of no growth factor (None) and 10 ng/ml BMP4 (BMP) on Days 0,
4, 6, and 8 (S.Fig.1). (B) Time-dependent increase in mesoderm gene transcripts. HES3 cells were differentiated in the presence of no
factor (None ), 10 ng/ml BMP4 (BMP ), or 100 ng/ml WNT3a (WNT ). RNAs were isolated from EBs on the days indicated
and real-time RT-PCR was performed using primers for the T, MESP1, CD34, CDH5, and FOXF1transcripts. The data shown represents
one of three independent experiments (another data set shown in S.Fig.2).
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Day 5. Slightly later, expression of CDH5 and CD34 mRNAs,
markers for hematoendothelial precursor cells, became
detectable (sometime between Day 2 and Day 5, and between
Day 5 and Day 8, respectively) and their levels steadily rose in a
time-dependent manner, especially in the presence of WNT3a.WNT signaling favors the development of
hematopoietic progenitor cells from hES cellsBased on the observation that both WNT and BMP signaling
positively affect the genesis of KDR+ cells, we examined
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level of hematopoietic and/or endothelial cell production
from hES cells. We first applied the hemogenic assay
originally developed for the mouse FLK1+PDGFRα-(CDH5-)
hemogenic mesoderm (Nakayama et al., 2003) to quantify
the hematopoietic potential of the hEB cells. EBs generated
in the presence of no factor, BMP4 (10 or 50 ng/ml), or
WNT3a (100 ng/ml) were dissociated into single cells, and
1×105 cells from each EB culture were seeded onto OP9 cells
and cocultured in the presence of human Stem Cell Factor
(hSCF), human interleukin-3 (hIL3), human thrombopoietin
(hTPO), and human granulocyte macrophage-colony stimu-
lating factor (hGM-CSF). Four days later, all cells from each
coculture were subjected to the secondary methylcellulose
culture (Nakayama et al., 2003). Total erythro-myeloid
colonies including those formed by colony-forming unit
erythroid (CFU-E), burst-forming unit erythrocyte (BFU-E),
colony-forming unit macrophage/monocyte (CFU-M), colony-
forming unit granulocyte (CFU-G), and erythroid-monocyte/
macrophage mixed colony-forming unit (CFU-EM) as shown in
Fig. 2A (left) were scored. A significant level of erythro-
myeloid (EM)-colony-forming cell (CFC) was detected from
Day 5 of differentiation in the presence of WNT3a, but not in
the presence of BMP4 or in the absence of growth factors,
and the number increased in the following 3 days (S.Fig.3).
On Day 8, the CFC generated on OP9 cells reached 214±25.5/
105 EB cells, two orders of magnitude higher than those
obtained without growth factor or with BMP4 (Pb0.05)
(Fig. 2A right). In line with the low level of KDR+PDGFRαlo
cells (1–3%) in the absence of any exogenous growth
factors, CFCs generated on OP9 cells from these EB cells
were as low as 8.3±5.2/105 EB cells. Furthermore, in
contrast to the findings of other groups (Lu et al., 2007; Ng
et al., 2005), we noted a slight decrease in the number of
CFCs generated on OP9 cells, 6.5±3.5 or 0.5±0.5/105 EB
cells, when BMP4 was included during hES cell differentia-
tion at 10 or 50 ng/ml, respectively. Thus, WNT3a strongly
promotes hematopoietic progenitor cell development from
hES cells, and BMP4 itself cannot replace WNT in this
process.
Both WNTs and BMPs promote endothelial cell
development from hES cells
We next examined whether WNT or BMP can also differen-
tially influence endothelial cell development from hES cells.
A reduced number (2.5×104) of total EB cells were seeded
onto OP9 cells, and cultured for 7–10 days. The cultures
were then fixed with ethanol and indirect immunofluores-
cence staining was performed using antibodies for the
endothelial cell-specific markers, CD31 and CDH5 (VE-
cadherin). The CD31-positive or CDH5-positive colonies
formed on OP9 cells are shown in Fig. 2B. The number of
such endothelial-like cell colonies was scored as a mean of
quantifying the endothelial cell precursors developed from
hES cells (colony forming unit-endothelial cell, or CFU-End,
Fig. 2C). Spontaneous differentiation resulted in a significant
level of CFU-End: 37.8±4.7/2.5×104 EB cells. However,
when EBs were formed in the presence of 10 ng/ml BMP4, the
number of CFU-End cells increased by 2- to 3-fold (to 100±
12.2/2.5×104 EB cells). At 50 ng/ml BMP4, the proportion of
CFU-End cells was 86.5±11/2.5×104 EB cells. Therefore, theeffect of BMP4 on accentuating endothelial cell development
from hES cells tends to be saturated at a dose of 10 ng/ml. In
contrast, consistent with the results from the erythro-
myeloid CFC assay, in the presence of WNT3a, hES cells
gave rise to dramatically higher numbers of CFU-End,
reaching 233.4±15.5/2.5×104 EB cells, an increase of
approximately 2-fold over the number with BMP4 alone
(Fig. 2C).
Collectively, these observations demonstrate a robust
effect of WNTsignaling in promoting both hematopoietic and
endothelial cell development from hES cells. In contrast,
BMP4 does not effectively specify hematopoietic progenitor
cells, but enhances angiogenic cell development.
Transcripts representing hemoangiogenic activity
accumulated in the KDR+PDGFRαlo progeny
Hemoangiogenic progeny developed from mES cells are
enriched in the FLK1(KDR)+PDGFRα- cell fraction (Nakayama
et al., 2003). To determine whether the hES-derived hemoan-
giogenic progeny are also enriched in the KDR+PDGFRαlo
fraction, we quantified the relative expression levels of
hematoendothelial cell–associated genes such as TAL1,
RUNX1, CD34, and CDH5, in the sorted populations of DN,
KDR-PDGFRα+, DP, and KDR+PDGFRαlo cells (Fig. 3A). Among
four subpopulations of Day 8 EB-derived cells, expression levels
of all transcripts were readily detected in the KDR+PDGFRαlo
cells generated in the presence of either WNT3a or BMP4, but
almost undetectable in other fractions (Fig. 3B). Therefore,
analogous to the mES cell-derived hemoangiogenic cells, the
KDR+PDGFRαlo cells derived from hES cells seem to be
specifically enriched in the hemoangiogenic cells. Interest-
ingly, these transcripts always accumulated to a higher level in
WNT3a-induced KDR+PDGFRαlo cells (black bar) than those
induced by BMP4 (white bar), supporting our previous results
that WNT3a is better than BMP4 at stimulation of the
generation of hemoangiogenic cells from hES cells.
WNT, rather than BMP, stimulates genesis of
hemogenic activity in the KDR+PDGFRαlo
cell fraction
We addressed whether the KDR+PDGFRαlo progeny were
capable of generating hematopoietic progenitors and
whether such activity was different in the KDR+PDGFRαlo
progeny generated in the presence of WNT3a or BMP4, as
predicted by the transcript analysis (Fig. 3B). The Fluores-
cence-Activated Cell Sorting (FACS)-purified cell fractions
were each cultured on OP9 cells for 15 days in the presence
of hSCF, hTPO, hIL3, and hGM-CSF. Whether generated in the
presence of WNT3a or BMP4, only the KDR+PDGFRαlo cells
gave rise to nonadherent (hematopoietic) cell foci (Fig. 3C,
left), and the accumulated cells were CD45+CD33+ myeloid-
like cells (Fig. 3C, right). The KDR+PDGFRαlo cells from
WNT3a-treated EBs generated more hematopoietic foci than
those from BMP4-treated EBs (data not shown).
To obtain more precise differences, the FACS-purified EB
fractions were each subjected to erythro-myeloid CFC assay
to determine whether hematopoietic progenitor cells were
already present and also to the hemogenesis assay, i.e.,
erythro-myeloid CFC assay after brief culture on OP9 cells to
Figure 2 WNTand BMP signaling are both implicated in the generation of hematoendothelial cells from hES cells. (A) Factor-dependent
generation of erythro-myeloid (EM)-CFCs during hES cell differentiation. Hematopoietic differentiation was evaluated by development of
EM-CFCs. HES3-EBs were formed in the presence of no factor (None), 10 ng/ml BMP4 (BMP 10), 50 ng/ml BMP4 (BMP 50), or 100 ng/ml
WNT3a (WNT). EBswereharvestedonDay 8 and resultant cellswereplatedat 1×105 cells/OP9well in 6-well plate, cultured for 4 days, and
transferred to secondarymethylcellulose culture.Day 11CFCs fromWNT3a-treated EB cells are shown (left). Total EM-CFCswere counted,
and averaged over 3 independent experiments (right). Prior to these experimenst, time course experiments were performed in the
presence of no factor (None), 10 ng/ml BMP4 (BMP), and 100 ng/mlWNT3a (WNT). EBs were harvested onDays 0, 3, 5, and 8 and subjected
to the same assay (S.Fig.3). (B) Endothelial differentiation was evaluated by development of CD31/CDH5+ colonies (CFU-End). The Day 8
EB cells generated as in (A) were plated at 2.5×104 cells/OP9well in 6-well plate, and continuously cocultured for 7 days. The endothelial
colonies were detected by anti-hCD31 antibody (upper panels, green) or anti-hCDH5 antibody (lower panels, green). The nuclei were
counterstained with DAPI (blue). (Left) The images merged with brightfield. (Right) the images emerged with DAPI. Scale bar: 50 μm. (C)
Factor-dependent generation of CFU-End during hES cell differentiation. The CD31+ colonies formed in (B) were counted and averaged
over 3 independent experiments. The error bars in (A) and (C) indicate plus or minus SEM., ⁎⁎⁎ Pb0.001, ⁎⁎ Pb0.01.
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cells were present (Fig. 3A). When any of the sorted fractions
was directly subjected to the erythro-myeloid CFC assay no
erythro-myeloid colonies were formed, indicating no ery-
thro-myeloid progenitors present in Day 5 and 8 EBs (Fig. 3D,
white bar). However, when the erythro-myeloid CFC assay
was performed after coculture on OP9 cells for 3–4 days, the
KDR+PDGFRαlo cell fraction specifically gave rise to many
erythro-myeloid colonies, evident in Day 5 and 8 EBs (black
bar). Addition of WNT3a was required to induce such activity
(Fig. 3D, “WNT”). The KDR+PDGFRαlo cells produced in the
presence of BMP4 alone displayed 0.5–1.0% the levels of
hemogenic activity (Fig. 3D “BMP”), analogous to the results
obtained with total EB cells (Fig. 2).
These results indicated that the KDR+PDGFRαlo progeny
are the intermediate cell type (i.e., hemogenic mesoderm or
its derivatives) in the developmental pathway from hES cells
to hematopoietic cells and that active WNT signaling is
required for effective generation of such cells. BMP signaling
cannot substitute for WNT signaling in this role.BMP signaling mediates WNT-dependent stimulation
of hemoangiogenic cell development from hES cells
It has been widely accepted that the addition of BMP4 or
BMP4 plus VEGF is effective in supporting hematopoietic cell
development from hES cells (Chadwick et al., 2003; Kennedy
et al., 2007). Recently, WNTs have also been shown to
enhance hematoendothelial cell development from hES cells
on mouse stromal cell lines (Woll et al., 2008). The
interaction between WNT and BMP signaling during early
embryogenesis has been well established (Verheyen, 2007;
Fuentealba et al., 2007; Messenger et al., 2005).
Therefore, we addressed whether the robust WNT3a
effects on hemoangiogenic cell development from hES cells
were related to BMP signaling. When the BMP inhibitor
Noggin was added with WNT3a during hES cell differentia-
tion, the PDGFRα+ cell populations and the KDR+PDGFRαlo
hemoangiogenic cell population were reduced to 20–30% of
the level obtained with WNT3a (i.e., to the level of Noggin
alone), as noted by Day 5 of differentiation (Figs. 4A and 5B).
118 Y. Wang, N. NakayamaIn Day 8 EBs, coaddition of Noggin with WNT3a prevented
the strong induction of hemogenic activity (i.e., activity
generating erythro-myeloid CFCs on OP9 cells) observedwith WNT3a alone (Fig. 4C, white and black bars). The
additional presence of Noggin also caused a marked
decrease in CFU-End production from hES cells stimulated
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results indicate that the WNT3a-dependent generation of
the KDR+PDGFRαlo hemoangiogenic cells from hES cells
requires the involvement of BMP signaling, probably acti-
vated by endogenously produced BMPs. In support of this
suggestion, quantitative RT-PCR analysis demonstrated that
the addition of Noggin severely inhibited the WNT3a-induced
expression of the hematoendothelial precursor cell tran-
scripts, e.g., CDH5 and CD34, during hES cell differentiation
(Fig. 4E).
As noted, there was a low level of differentiation in the
absence of exogenous factors (Figs. 1A, 4A, and 4B “None”).
However, spontaneous generation of hemogenic activity was
very weak, and when Noggin alone was added, no significant
effects were seen (Fig. 4C). In contrast, Noggin caused
significant reduction in the spontaneously generated
KDR+PDGFRαlo cell population (Figs. 4A and 4B “NOG”).
Therefore, the spontaneous generation of a majority of
KDR+PDGFRαlo cells from hES cells appears to be dependent
on endogenous BMP activity.
WNT signaling sustains BMP4-enhanced endothelial
cell development from hES cells
Conversely, we assessed whether BMP4-dependent upregula-
tion of endothelial precursor cell development during hES
cell differentiation involved WNT signaling. When the
canonical Wnt inhibitor DKK1 was added with BMP4, by Day
8 of differentiation, the effects of BMP4 on hES progenitor
distribution, i.e., strong elevation of the levels of PDGFRα+
cells and relatively weak upregulation of the level of the
KDR+PDGFRαlo cell population, were suppressed (Figs. 5A and
B, “BMP+DKK”). Furthermore, the population of hES-pro-
genitors expressing CD34 and CD31 (i.e., CD34+CD31+ cells)
surface markers for hematoendothelial cells was elevated by
BMP4 alone, but was significantly reduced by coaddition of
DKK1 (Fig. 5C).
When EB cells from BMP4-supplemented or BMP4+DKK1-
supplemented culture were subjected to CFU-End assay,
coaddition of DKK1 almost entirely suppressed the effect of
BMP4: the number of CFU-End was reduced to that from EBs
generated in the absence of protein factors (Fig. 5D, right,
black bar). There was no statistically meaningful reduction in
the hemogenic activity induced by BMP4 when DKK1 wasFigure 3 The effect of WNT and BMP signaling on the generation o
experimental procedure for fractionation of EB cells by FACS and their
EB cells developed in the presence of 10 ng/ml BMP4 (BMP) or 100 ng/
sorting. The sorted fractions, KDR+PDGFRαlo (K+Plo), KDR+PDGFRα+ (D
subjected to real-time RT-PCR using primers for CD34, CDH5, TAL1
markers such as T, MESP, and FOXF1 (S.Fig.4.) (C) Hematopoietic diff
KDR+PDGFRαlo cells isolated from WNT3a-treated EBs (WNT) or BMP4
15 days. Nonadherent cells were collected and stained with CD45 and
independent experiments. (Left) Representative image of the
magnification). (D) Generation of erythro-myeloid CFCs from the K
WNT3a (WNT) or BMP4 (BMP). On Day 5 (left) or Day 8 (right), EB cells
KDR+PDGFRα+ (DP), and KDR-PDGFRα+ (P+) cells (1.4×104 cells each) w
before (□) or after (◼) 4 days coculture on OP9 cells. Note that we di
previously showed no hematopoietic cell development on OP9. No
coculture (□). The total erythro-myeloid colonies were counted on D
The error bars in (B) and S.Fig.4, and (D) represent plus or minus SEMadded, probably because this effect of BMP4 was already
very weak (data not shown). Nevertheless, these results
indicate that enhancement of endothelial (precursor) cell
genesis from hES cells by BMP4 depends on the involvement
of canonical WNT signaling, likely to be activated through
endogenous WNTs.
Unlike hemogenic activity, the generation of CFU-End
remained at a significant level even in the absence of
exogenous factors (Fig. 5D, white bar). When DKK1 was
added, the occurrence of CFU-End was markedly reduced
(Fig. 5D, black bar), but the KDR+PDGFRαlo cell population
was not significantly affected (Figs. 5A and B “DKK”).
Therefore, endogenous WNTactivity is sufficient to generate
a low level of angiogenic cells from hES cells without
exogenous factors. Such cells probably represent only a
minor population of the KDR+PDGFRαlo cells generated.
Discussion
In this study we have demonstrated that the development of
KDR+PDGFRαlo hemoangiogenic cells from hES cells is depen-
dent on the cooperation ofWNTandBMP signaling. FLK1/KDR is
a marker for hemangioblast/hemoangiogenic mesoderm gen-
erated early in either mouse embryogenesis or mES cell
differentiation. The hemoangiogenic activity is further
enriched in a subtraction of FLK1+ cells that lacks PDGFRα,
another surface marker for mesoderm (i.e., FLK1+PDGFRα-)
(Nakayama et al., 2003). Similarly, progeny expressing KDR
and/or PDGFRα increased in a time- and factor- (e.g., WNT3a
and/or BMP4) dependent manner during hES cell differentia-
tion. Biological and transcriptional analyses of EB cells have
demonstrated for the first time that the KDR+PDGFRαlo
fraction exclusively contains hemoangiogenic activity derived
from hES cells, analogous to the FLK1+PDGFRα- cell popula-
tion from mES cells. Traditionally, surface markers such as
CD34, CD31, and CD45 have been used to identify and isolate
hematopoietic progenitors and their precursors from hES
cells (Wang et al., 2004; Zambidis et al., 2005; Woll et al.,
2008). In this study, we have provided a new means of
detecting and isolating hemoangiogenic cells from hES cells.
Furthermore, we have shown the existence of striking
conservation in the signaling events required for the differ-
entiation of mES and hES cells to hematopoietic and
endothelial cell lineages, and the cellular intermediatesf KDR+PDGFRαlo hemogenic cells. (A) Schematic diagram of the
biological characterization. (B) Gene expression profiling. HES3-
ml WNT3a (WNT) were harvested on Day 8, and subjected to FACS
P), KDR-PDGFRα+ (P+), and KDR-PDGFRα- (DN), were individually
, and RUNX1. The same samples were analyzed for mesoderm
erentiation of the isolated KDR+PDGFRαlo cells on OP9 cells. The
-treated EBs (BMP) were seeded on OP9 cells and maintained for
CD33 antibodies. Indistinguishable profiles were obtained from 3
hematopoietic focus developed on OP9 cells (×20 original
DR+PDGFRαlo cells. HES3-EBs were formed in the presence of
were fractionated by FACS, and the sorted KDR+PDGFRαlo (K+Plo),
ere individually subjected to secondary methylcellulose culture
d not include the KDR-PDGFRα- (DN) cell analysis here, since they
EM-CFCs were detected in any of the EB cell fractions without
ay 11. Typical colonies developed are shown in the upper panel.
of 3 independent experiments. ⁎⁎⁎ Pb0.001, ⁎⁎ Pb0.01, ⁎ Pb0.05.
Figure 4 WNT3a requires BMP signaling to generate hemoangiogenic cells from hES cells. (A) Flow cytometric analysis of EB cells. The
staining profile was acquired from Day 5 and Day 8 EBs formed with HES3 cells in the presence of no factor (None), 0.5 μg/ml Noggin
(NOG), 100 ng/ml WNT3a (WNT), or WNT3a and Noggin (WNT+NOG). The KDR-PDGFRα+, DP, and KDR+PDGFRαlo cell populations are
indicated as in Fig. 1A. (B) Effect of Noggin on generation of the KDR+PDGFRαlo cell population. The percentage of KDR+PDGFRαlo (K+Plo)
cells in EBs formed in (A) was averaged over 3 independent experiments. (C) The effect of Noggin on the hematopoietic differentiation
of hES cells. Day 8 EB cells generated as in (A) were cocultured with OP9 cells for 4 days, and then subjected to secondary
methylcellulose culture for the detection of EM-CFCs as in Fig. 2A. (D) The effect of Noggin on the development of endothelial cells
from hES cells. Some EB cells weremaintained on OP9 cells for 7 days and immunostained with anti-hCD31 antibody to score CFU-End as
in Fig. 2B. The numbers of CFCs and CFU-End in C and D were averaged over 3 independent experiments (n=3). The error bars in B, C,
and D indicate plus and minus of SEM, ⁎⁎⁎ Pb0.001, ⁎⁎ Pb0.01, ⁎ Pb0.05. (E) Expression of CD34 and CDH5 transcripts. HES3-EBs formed
as in (A) were harvested on Days 0, 2, 5, and 8, and subjected to real time RT-PCR using CD34 and CDH5 primers. The data shown in (E)
are representatives of 3 independent experiments. (None: ; NOG: ; WNT: ; WNT+NOG: ).
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Figure 5 BMP4 requires WNTsignaling to promote endothelial potential from hES cells. (A) Flow cytometric analysis of EB cells. HES3
cells were differentiated for 8 days in the presence of no factor (None), 0.5 μg/ml DKK1 (DKK), 10 ng/ml BMP4 (BMP), or BMP4 and
DKK1 (BMP+DKK), and analyzed by FACS for KDR and PDGFRα. The KDR-PDGFRα+, DP, and KDR+PDGFRαlo cell populations are indicated
in as in Fig. 1A. (B) Effect of DKK1 on the generation of KDR+PDGFRαlo cells. The percentage of KDR+PDGFRαlo (K+Plo) cells in EBs formed
as in (A) was averaged over 3 independent experiments. (C) Effect of DKK1 on the generation of CD34+CD31+ cells. HES3-EBs were
formed as in (A), and the percentage population of CD34+CD31+ cells was averaged over 3 independent experiments (Left). (D) Effect
of DKK1 on endothelial differentiation. The Day 8 EB cells generated as in (A) were maintained on OP9 cells for 7 days and
immunostained with anti-hCD31 antibody to score CFU-End as in Fig. 2B. The numbers of CFU-End were averaged over 3 independent
experiments (n=3). The error bars in B, D, and C indicate plus or minus SEM, ⁎⁎ Pb0.01, ⁎ Pb0.05.
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coordinately stimulate the genesis of FLK1+PDGFRα- hemo-
genic mesoderm in the mouse (Nakayama et al., 2000, 2003;
Lengerke et al., 2008) and KDR+PDGFRαlo hemogenic meso-
derm in humans. As a result of limited access to early human
embryos, it has not been possible to demonstrate a role for
WNT and BMP signaling on specification and/or formation of
hemogenic mesoderm in vivo. However, these results suggest
that the regulation of hematopoietic differentiation during
early development might be similar between the two species.
It has been reported that generation of CD34+CD31+ or
CD34+FLK1+ cells is enhanced by overexpression of Wnt1 by the
stromal cells on which the hES cells were differentiated in a
serum-containing medium (Woll et al., 2008). However, our
study has provided quantitative data showing a dominant
effect of WNT3a over BMP4 on the hemoangiogenic cell
development, and also defined the stage of differentiation inwhich WNT signaling takes a critical role in enhancing the
overall hematopoietic differentiation. For example, the gene
expression analysis indicated hemogenic potential only in the
KDR+PDGFRαlo cell population generated by Day 8 in the
presence ofWNT3a. These cells showed no CFC activity without
OP9 coculture (Fig. 3). After only a brief coculture with OP9,
they displayed CFC activity, analogous to mouse FLK1+PDGFRα-
cells isolated from Day 5 EBs. These results suggest that the
KDR+PDGFRαlo cells undergo transition from early hemogenic
cells to hematopoietic progenitor cells during this period, and
therefore that WNT signaling is required for the formation of
the hemogenic mesoderm/endothelium, a stage before com-
mitment to hematopoietic progenitors (Woll et al., 2008).
It has long been appreciated that integration of multiple
signaling pathways is required for cell-type specification
during embryogenesis. For instance, a growing body of
evidence supports the view that WNT and BMP signaling can
122 Y. Wang, N. Nakayamainfluence one another's behavior through crosstalk. In Xeno-
pus, Brachyury (Xbra), a direct downstream target of Wnt
signaling, can interact with Smad1 in response to BMP4,
thereby enhancing the ventralizing activity via a BMP signal
transduction pathway and causing the down regulation of
goosecoid (Messenger et al., 2005). Moreover, during the
process of patterning in Xenopus, canonical Wnt signaling
regulates the duration of BMP signal via a cascade of events,
such as phosphorylation and translocation of Smad1 in the cells
(Fuentealba et al., 2007).We have clearly demonstrated in the
present study that the cooperation of WNTand BMP signaling is
essential for generating early hemogenic cells during hES cell
differentiation. We found that blockage of BMP action by
Noggin virtually abolished the stimulatory effect of WNT3a on
hematopoietic differentiation of hES cells. On the other hand,
BMP-stimulated endothelial differentiation is dependent on
the involvement of endogenous WNT signaling, likely via
canonical WNT signaling pathways, as evidenced by inhibition
in the presence of DKK1. Considering the recent finding by
Sumi and co-workers, in which stabilization of β-catenin and a
sustained level of BMPdefine specification of nascent primitive
streak from hES cells (Sumi et al., 2008), our observations
suggest that bothWNTand BMP signaling are indispensible, not
only for developing earlymesoderm but also for its subsequent
maturation into hemogenic mesoderm/endothelium.
The genesis of hemoangiogenic cells from hES cells is
effectively stimulated by WNT3a provided exogenously.
Endogenous WNTs secreted by EB cells do contribute to the
genesis of CFU-End in the absence or presence of BMP4
(Fig. 5). However, such WNTs did not result in a significant
increase in hemogenic activity (Fig. 4). We prefer to
speculate that an appropriate balance between the
strengths of WNT and BMP signaling may be important. For
example, a high level of WNT signaling (from exogenous
WNT3a) in conjunction with a lower level of BMP signaling
(form endogenous BMPs) may preferentially support hema-
topoietic cell development, while a low level of WNT
signaling (from endogenous WNTs) with a stronger BMP
signaling (from exogenous BMP4) might shift the bias toward
endothelial cell differentiation. Alternatively, the endogen-
ous WNTs produced spontaneously or induced by BMP4 may
be different from WNT3a, which may activate different
signaling pathways and/or may stimulate different types of
cells during ES cell differentiation. Further research is
required to test these possibilities. The data presented
here were acquired from HES3 cells. Similar results have also
been observed with MEL1 cells (data not shown).
Materials and methods
Cell culture and maintenance of hES cells
HES3 and MEL1 hES cells were grown as a bulk culture on
irradiated primary mice embryonic fibroblasts (MEFs) at a
density of 1.2×104 cells/cm2 in SR medium consisting of
Dulbecco-modified Eagle Medium (DMEM): Ham's F12 (1:1), 20%
Knockout SerumReplacement (KSR), 2mML-glutamine, 0.1mM
nonessential amino acids (all from Invitrogen, Carlsbad, CA),
and 90 μM β-mercaptoethanol (Sigma-Aldrich, St Louis, MO),
supplemented with 4 ng/ml human fibroblast growth factor 2
(FGF2, R&DSystems.Minneapolis,MN).MEFswere expandedup
to passage 6 before irradiation. HES3 cells used for differentia-tion were maintained up to passage 10–12, by which time
pluripotency and normal karyotype had been confirmed.
Differentiation of hES cells
One week before differentiation, HES3 cells were collected
as clumps using 4 mg/ml collagenase (Worthington Biochem-
ical, Lakewood, NJ) and plated at a 2× higher density in a T75
MEF-flask. On the day of differentiation, HES3 cells reaching
up to 70–80% confluence were harvested as clumps using
collagenase. The clumps were enriched by sedimentation
followed by brief centrifugation at 500 rpm for 2 min at room
temperature (RT) prior to resuspension in SR medium (5–
6 ml/hES cell clumps from one T75-flask) and subsequent
careful dissociation into smaller aggregates (approximately
100–200 cells per aggregate) by repeated pipetting. The
number of aggregates in 10 μl was counted 3–4 times, and the
aggregates were resuspended in SR medium without FGF2.
Approximately 13–14×103 aggregates were added to 16 ml/
10-cm dish of EB formation medium: Iscove-modified
Dulbecco medium (IMDM, Sigma), 15% (v/v) KSR, 100 μg/ml
human holo-transferrin (Sigma), 10 μg/ml bovine insulin
(Sigma), and 0.45 mM monothioglycerol (MTG, Sigma), 0.9%
(w/v) methylcellulose (Stem cell Technologies, Vancouver,
BC, Canada), supplemented with or without growth factors,
e.g., BMP4 (human, R&D Systems) at 10–50 ng/ml, and
WNT3a (mouse, Australian Stem Cell Centre) at 25–100 ng/
ml. The EB cultures were performed at 37 °C under 5% CO2,
5% O2.
Flow cytometry
On Day 5 or Day 8 of differentiation, EBs were harvested and
dissociated into single cells by incubation with collagenase
mix, 0.25% (w/v) collagenase B:collagenase D (1:1) (Roche
Applied Science, Castle Hill, NSWAustralia) for 15 min, or with
TrpLE-Select (Invitrogen) for 3 min at 37 °C, followed by
incubation in nonenzymatic cell dissociation buffer (Invitro-
gen) for 10 min at 37 °C, and then by repetitive pipetting with
a 1-ml pipette (BD Biosciences, San Jose, CA). Remaining
clumps were removed with a 40-μm strainer (BD). Cells were
resuspended at 5×106 cells/ml in 0.5% (w/v) bovine serum
albumin (BSA, Sigma) in Dulbecco's phosphate-buffered saline
without Ca2+ and Mg2+ (PBS, Invitrogen). The cells were
stained with purified mouse anti-human PDGFRα (BD) and
anti-human FLK1/KDR (RELIATech, Braunschweig, Germany)
monoclonal antibodies at 5–10 μg/ml. PDGFRα was visualized
with biotin-conjugated goat anti-mouse IgG2 (Southern
Biotech), followed by streptavidin-PE-Cy7 (BD Pharmingen),
and KDR was detected with PE-conjugated goat anti-mouse
IgG1 (Southern Biotech). The stained sample was analyzed by
FC500 (Beckman-Coulter, Fullerton, CA), or sorted for PDGFRα
and KDR markers using the FACS DIVA (BD). Live cells were
pregated with propidium iodide (PI, Sigma). Prior to total EB
cell assays, live EB cells were collected by FACS using PI.
Hematopoietic and endothelial cell genesis on OP9
stromal cells
OP9 cells were maintained and expanded in α-modified
Minimal Essential Medium (α-MEM, Invitrogen), 15% (v/v)
123WNT and BMP signaling are both required for hematopoietic cell development from human ES cellsfetal bovine serum (FCS, Hyclone, Logan, UT) in T75 or T175
flasks. One day prior to coculture, the OP9 cells were seeded
at density of 8×104 cells/well of a 6-well plate, precoated
with 0.1% (w/v) porcine skin gelatin (Sigma) for 1 h. The FACS-
purified EB cells and total EB cells were plated at 1–4×104
cells/well and 0.25–1×105 cells/well, respectively, onto an
80–90% confluent OP9 cell layer and were maintained in α-
MEM, 5% FCS, 0.1 μM MTG in the presence of 100 ng/ml hSCF
(Amgen, Thousand Oaks, CA), 100 ng/ml hTPO (Millipore,
Billerica, MA), 20 ng/ml hIL3 (Millipore), and 20 ng/ml hGM-
CSF (Millipore). The cultures were maintained at 37 °C under
5% CO2, and half themediumwas changed every 4–5 days. For
the hemogenesis assay, the whole cocultures were harvested
by a brief TrpLE-Select treatment on Day 3–4.
Serum-free erythro-myeloid colony-forming cell
assay
OP9-cultured or uncultured EB cells were added to serum-
free CFC medium consisting of IMDM, 10% BSA (Stem Cell
Tech), 2% (v/v) chemically defined lipid concentrate
(Invitrogen), 100 μg/ml human holo-transferrin, 10 μg/ml
bovine insulin, 0.1 μMMTG, and 1%methylcellulose (Stem Cell
Tech) (Nakayama et al., 2003; Heyworth and Spooncer, 1993;
Coutinho et al., 1993), supplemented with 20 ng/ml hIL3,
100 ng/ml hSCF, 50 ng/ml human granulocyte colony stimulat-
ing factor (hG-CSF, Millipore), 20 ng/ml hGM-CSF, 25 ng/ml
hIL6, and 3 U/ml human erythropoietin (hEPO, Millipore). The
cell mix was divided among two to four 35-mmbacterial-grade
dishes (Simport), andmaintained at 37 °C under 5%CO2, 5%O2.
On Day 11, total colonies including those formed by CFU-E,
BFU-E, CFU-M, CFU-G, and CFU-EM were counted. Images of
colonies were acquired using the Olympus BX51 microscope
(Olympus,North Ryde,NSW, Australia), equippedwith a digital
camera, DP70 (Olympus, or Motic MCC).
Endothelial cell colony-forming assay
After 7–10 days of coculture with OP9 cells, adherent cells
were fixed with 100% cold ethanol (precooled at -20 °C for at
least 30 min) for 10 min and dried at RT prior to being blocked
with 10 μg/ml goat IgG in 0.5% BSA (in PBS) for 10 min at
37 °C and subsequently stained with mouse anti-human CD31
antibody (DAKO, Glostrup, Denmark) or mouse anti-human
CDH5 (VE-cadherin) antibody (DAKO) at a concentration of
20 μg/ml for 1 h at RT. Cells were washed three times with
0.5% BSA and incubated with AlexaFluor 488-conjugated goat
anti-mouse IgG (Molecular Probes) for 30 min at RT. Following
three 10-min washes with 0.5% BSA, nuclei were stained and
mounted with DAPI fluorescence mounting medium (Vector
Laboratories, Burlingame, CA). Immunofluorescence was
visualized using a fluorescent microscope IX71 (Olympus)
and images were captured with U-CMAD3 camera (Olympus).
Real-time RT-PCR analysis
Total RNA was prepared with the RNeasy micro kit (Qiagen,
Doncaster, VIC, Australia) and treated with RNase-free
DNase (Qiagen). Total RNA, 0.25–1 μg, was reverse-
transcribed into cDNA with Superscript III Reverse Tran-
scriptase using Oligo dT20 (Invitrogen). Real-time quanti-tative PCR was performed using the ABI 7500 (Applied
Biosystems, Foster City, CA). All experiments were performed
in duplicate using either ABI SYBR Green Mix and gene-specific
primers or ABI Taqman Mix and Taqman Gene Expression Assay.
The oligonucleotide sequences and PCR cycle conditions are
listed in S.Table 1. The eukaryotic translation elongation
factor 1 alpha 1 (EEF1A1) gene was used as a reference
housekeeping gene. The relative expression was deter-
mined based on 2-ΔΔCT (= 2-(ΔCT-ΔCT0) =2ΔCT0/2ΔCT), according
to the manufacturer's recommendation. We assumed
calibrator to be constant, so that the relative expression
was calculated as 1000/2ΔCT.
Statistical analysis
Differences between groups were compared using the
Student t test. Statistical analysis was performed using
Prism 5 (GraphPad Software, San Diego, CA). Results were
considered not significant (ns) at P values of 0.05 or more.
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